Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121240562 | 12124056 | 2 | F | 20160920 | 20160229 | 20160923 | PER | US-PFIZER INC-2016112899 | PFIZER | 23.00 | YR | F | Y | 0.00000 | 20160923 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121240562 | 12124056 | 1 | PS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | 100 MG, 1X/DAY | U | 21992 | 100 | MG | PROLONGED-RELEASE TABLET | QD | ||||||
| 121240562 | 12124056 | 2 | C | KLONOPIN | CLONAZEPAM | 1 | 1 MG, UNK | 0 | 1 | MG | TABLET | ||||||||
| 121240562 | 12124056 | 3 | C | ATARAX | HYDROXYZINEHYDROXYZINE HYDROCHLORIDE | 1 | 10 MG, UNK | 0 | 10 | MG | TABLET | ||||||||
| 121240562 | 12124056 | 4 | C | ADVIL | IBUPROFEN | 1 | 800 MG, UNK | 0 | 800 | MG | TABLET | ||||||||
| 121240562 | 12124056 | 5 | C | MOTRIN | IBUPROFEN | 1 | 800 MG, UNK | 0 | 800 | MG | TABLET | ||||||||
| 121240562 | 12124056 | 6 | C | EFFEXOR | VENLAFAXINE HYDROCHLORIDE | 1 | 75 MG, UNK | 0 | 75 | MG | TABLET |
Indications of drugs used
| no results found |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121240562 | 12124056 | Dizziness | |
| 121240562 | 12124056 | Drug dose omission |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |